Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity
about
Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese ratObesity and addiction: neurobiological overlapsDevelopmental pesticide exposure reproduces features of attention deficit hyperactivity disorderObesity: Current and potential pharmacotherapeutics and targets.Feeding and reward: ontogenetic changes in an animal model of obesityLeptin increases striatal dopamine D2 receptor binding in leptin-deficient obese (ob/ob) mice.Reward, dopamine and the control of food intake: implications for obesity.Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.Bromocriptine increased operant responding for high fat food but decreased chow intake in both obesity-prone and resistant rats.Chronic forced exercise during adolescence decreases cocaine conditioned place preference in Lewis rats.Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner?Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats.Obese and lean Zucker rats demonstrate differential sensitivity to rates of food reinforcement in a choice procedureObese rats with deficient leptin signaling exhibit heightened sensitivity to olfactory food cues.Cardiovascular changes in animal models of metabolic syndromeCoupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms.Kynurenic acid, an aryl hydrocarbon receptor ligand, is elevated in serum of Zucker fatty rats.Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats.Serotonin Transporter Binding in the Diencephalon Is Reduced in Insulin-Resistant Obese Humans.Bromocriptine inhibits adipogenesis and lipogenesis by agonistic action on α2-adrenergic receptor in 3T3-L1 adipocyte cells.Perturbed Development of Striatal Dopamine Transporters in Fatty Versus Lean Zucker Rats: a Follow-up Small Animal PET Study.Changes in gene expression and sensitivity of cocaine reward produced by a continuous fat diet.Brief exposure to obesogenic diet disrupts brain dopamine networks.Diet matters: Glucocorticoid-related neuroadaptations associated with calorie intake in female rhesus monkeys.Leptin attenuates D2 receptor-mediated inhibition of putative ventral tegmental area dopaminergic neurons.Central lipid detection and the regulation of feeding behavior
P2860
Q24602893-91DCAC8E-9D30-4BC5-881C-F500CD5ECC5CQ26827446-05DC6225-9166-48B2-A865-B9A273020449Q27319295-4D3A6267-9182-46A2-8580-E839CC0E9C1FQ30243992-C4FE9512-EB20-4B47-97E9-C0AB16D729A2Q33815714-F1AD2AD8-8BEA-4725-ACE7-8D32F1279D8DQ33862970-943F5B8B-13EB-4483-BCFC-804F3E236686Q34151929-7F1F2ED7-FA34-4D11-A40A-490DB6A64A59Q34305557-8D55FC90-7D46-48C9-AEC3-9C3052A7C3FFQ34476706-D15721D7-5BA1-49D9-9129-3166B809E5C4Q35282281-DD626E49-1ED6-4624-A90E-764647B62710Q36100262-FE95A5C2-1A37-4040-8395-8A4D79EE1476Q36336425-A71D77A5-58B3-4F56-A022-A224D3C82262Q36442282-61C0215B-4A3F-45CA-AC6D-B676A69BD5D8Q36626090-5157AAB3-3924-4AE9-B60A-E5E5D3F4F8B3Q36825744-59DB92C3-A2D7-414A-9894-0D1B7DC670C9Q37237466-50BA4F39-D0EB-402E-B16D-D32436AE450FQ37326812-EEC75E35-EBA5-4741-B377-A869964AB9BAQ37609291-A6659482-D5EB-4006-B4B0-16246D604E9AQ42375205-19AA45BB-7019-4B77-A177-17D81A33D5ADQ42827441-14ABCE5A-F843-4AD6-83AD-17B8109CC241Q48401453-77D6F9E8-E51B-4CB6-9D99-752C4C18952DQ50440819-88CC9D1B-F5B5-4271-BACB-C1A0AB36BF97Q52691906-1964132D-3272-47BE-B527-7883C9FE9AB6Q53428062-9CB9BCE4-8CF7-48E6-90F2-557E07985EBBQ54940204-86FB5683-AF32-45F2-B3D0-F964405332ACQ57600743-0438259F-6F3C-48EB-949A-877498D05CC4
P2860
Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Bromocriptine administration r ...... rats with diet-induced obesity
@en
Bromocriptine administration r ...... ats with diet-induced obesity.
@nl
type
label
Bromocriptine administration r ...... rats with diet-induced obesity
@en
Bromocriptine administration r ...... ats with diet-induced obesity.
@nl
prefLabel
Bromocriptine administration r ...... rats with diet-induced obesity
@en
Bromocriptine administration r ...... ats with diet-induced obesity.
@nl
P2093
P2860
P356
P1433
P1476
Bromocriptine administration r ...... rats with diet-induced obesity
@en
P2093
Carlo Contoreggi
Gene Jack Wang
Karen McCullough
Lawrence J Cheskin
Lisa M Davis
Michael Michaelides
Nora D Volkow
Panayotis K Thanos
Paul A Watkins
P2860
P304
P356
10.1159/000170586
P50
P577
2008-11-04T00:00:00Z